Inventor · disambiguated record
Carl T. Wild
Also filed as: CHEN CHIN-HO · PETTEWAY STEPHEN ROBERT · WILD CARL T · WILD CARL THOMAS
19 granted patents·14 pending applications·610 citations·filing 1993–2019
95Inventor score
Files withPANACOS PHARMACEUTICALS INC9UNIV DUKE8TRIMERIS INC5HETERO LABS LTD3US GOV HEALTH & HUMAN SERV2
Top patents by PatentIndex Score
33 records- 0197US5464933ASynthetic peptide inhibitors of HIV transmissionUNIV DUKE·Filed 1993·Granted Nov 7, 1995·270 cites·19 claims
- 0292US5656480ACompounds which inhibit HIV replicationUNIV DUKE·Filed 1995·Granted Aug 12, 1997·121 cites·16 claims
- 0389US7365221B2Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereofPANACOS PHARMACEUTICALS INC·Filed 2004·Granted Apr 29, 2008·32 cites·23 claims
- 0489US6479055B1Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmissionTRIMERIS INC·Filed 1995·Granted Nov 12, 2002·44 cites·44 claims
- 0588US7122190B2Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aidsUNIV DUKE·Filed 2002·Granted Oct 17, 2006·15 cites·9 claims
- 0684US7273614B2Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aidsUNIV DUKE·Filed 2003·Granted Sep 25, 2007·9 cites·16 claims
- 0783US9868758B2Betulinic proline imidazole derivatives as HIV inhibitorsHETERO LABS LTD·Filed 2015·Granted Jan 16, 2018·3 cites·13 claims
- 0882US7311916B2Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41US GOV HEALTH & HUMAN SERV·Filed 2003·Granted Dec 25, 2007·16 cites·16 claims
- 0978US6824783B1Methods for inhibition of membrane fusion-associated events, including HIV transmissionUNIV DUKE·Filed 1995·Granted Nov 30, 2004·21 cites·118 claims
- 1078US6133418ASynthetic peptide inhibitors of HIV transmissionUNIV DUKE·Filed 1995·Granted Oct 17, 2000·31 cites·3 claims
- 1176US6605427B2Assay for detection of viral fusion inhibitorsPANACOS PHARMACEUTICALS INC·Filed 2001·Granted Aug 12, 2003·14 cites·19 claims
- 1271US6768007B2Substituted 3′,4′-di-O-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereofPANACOS PHARMACEUTICALS INC·Filed 2002·Granted Jul 27, 2004·5 cites·23 claims
- 1370US7537765B2Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 proteinPANACOS PHARMACEUTICALS INC·Filed 2004·Granted May 26, 2009·3 cites·40 claims
- 1465US6440656B1Methods for the inhibition of respiratory syncytial virus transmissionTRIMERIS INC·Filed 1994·Granted Aug 27, 2002·13 cites·13 claims
- 1563US6573078B1Compounds which inhibit HIV replicationUNIV DUKE·Filed 1995·Granted Jun 3, 2003·13 cites·26 claims
- 1661US2003181382A1Compounds which inhibit HIV replicationUNIV DUKE·Filed 2003·Application pending·0 cites
- 1759US2008233559A1Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 ProteinUS GOV HEALTH & HUMAN SERV·Filed 2007·Application pending·0 cites
- 1859US2010291680A1Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmissionTRIMERIS INC·Filed 2010·Application pending·0 cites
- 1958US2007037141A1Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmissionTRIMERIS INC·Filed 2003·Application pending·0 cites
- 2057US2008039428A1Antiretroviral combination therapyPANACOS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2156US8318425B2Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 proteinSALZWEDEL KARL·Filed 2009·Granted Nov 27, 2012·0 cites·1 claims
- 2254US2007202127A1Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aidsTRIMERIS INC·Filed 2006·Application pending·0 cites
- 2351US2008200550A1Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 ProteinVI TECHNOLOGIES INC·Filed 2005·Application pending·0 cites
- 2450US2011142847A1Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41PANACOS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2546US2004265320A1Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 proteinFiled 2004·Application pending·0 cites
- 2646US2002010317A1Method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of HIV envelope proteinsFiled 2001·Application pending·0 cites
- 2744US11236122B2Triterpene amine derivativesDFH THERAPEUTICS·Filed 2019·Granted Feb 1, 2022·0 cites·14 claims
- 2844US2004131629A1Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereofPANACOS PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2942US2004132011A1Method for detecting viral inactivating agentsPANACOS PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 3039US10669305B2C-3 novel triterpenone with C-28 urea derivatives as HIV inhibitorsHETERO LABS LTD·Filed 2016·Granted Jun 2, 2020·0 cites·11 claims
- 3139US2006205697A1Novel betulin derivatives, preparation thereof and use thereofROBINSON GARY N·Filed 2005·Application pending·0 cites
- 3238US2005148561A1Novel triterpene derivatives, preparation thereof and use thereofPANACOS PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3330US10370405B2C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitorsHETERO LABS LTD·Filed 2016·Granted Aug 6, 2019·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Carl T. Wild files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →